• IMPORTANCE OF PARALLEL IMPORTATION OF PATENTED MEDICINES DUE TO ONGOING COVID-19 CRISIS

    Author(s):
    Nivedita Singh, Army Law College, Pune, Rakshita Singh, Army Law College, Pune
    Editor(s):
    Nyaay Shastra (see profile)
    Date:
    2021
    Subject(s):
    Law
    Item Type:
    Article
    Permanent URL:
    http://dx.doi.org/10.17613/7hm2-ed80
    Abstract:
    The second wave of Covid-191 has brought about havoc in the healthcare system. The shortage of medicines such as Remdesivir2 has resulted in the denial of proper medical treatment to numerous patients. Medicines are patented due to the intellectual efforts, research, and labor of the R&D department of a company. However, in the current public health crisis, should monopoly rights that cover every aspect of Covid-19 response from vaccines to medicines be given priority over public policy? Granting compulsory licenses to other manufacturers is another way to go about it, but this would prolong the pandemic as it takes time to introduce fresh stock to the market and the requirement is immediate. This article deals with two crucial questions, how parallel importation of patented medicines is an immediate solution to the current crisis and how our Patents Act, 19703 is robust enough to deal with it.
    Metadata:
    xml
    Published as:
    Journal article     Show details
    Publisher:
    Nyaayshastra Law Review
    Pub. Date:
    18-05-2021
    Journal:
    NyaayShastra Law Review
    Volume:
    2
    Issue:
    1
    Page Range:
    https://www.nyaayshastra.com/volume-2-issue-1 -
    ISSN:
    2582-8479
    Status:
    Published
    Last Updated:
    2 years ago
    License:
    All Rights Reserved
    Share this:

    Downloads

    Item Name: pdf importance-of-parallel-importation-of-patented-medicines-due-to-ongoing-covid-19-crisis.pdf
      Download View in browser
    Activity: Downloads: 107

    Back to Deposits